Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR5 | P35346 | 19/20 | 0.69 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.69 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4592324 | 0.92 | SSTR5 (0.72) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2955914 | 0.84 | SSTR5 (0.70) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2955934 | 0.84 | SSTR5 (0.77) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2956503 | 0.82 | SSTR5 (0.82) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2964793 | 0.82 | SSTR5 (0.82) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2958311 | 0.81 | SSTR5 (0.69) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2960329 | 0.81 | SSTR5 (1.00) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2958019 | 0.81 | SSTR5 (0.81) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL2957230 | 0.81 | SSTR5 (0.75) | SSTR5KCNH2RAB9ASSTR1HRH1 | |
| SCHEMBL4591321 | 0.81 | SSTR5 (0.74) | SSTR5KCNH2SSTR1HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1893603-A1 | PIPERIDIN-4-YL-AMIDE DERIVATIVES AND THEIR USE AS SST RECEPTOR SUBTYPE 5 ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2008-03-05 | — | — | EP | disclosed |
| WO-2006128803-A1 | PIPERIDIN-4-YL-AMIDE DERIVATIVES AND THEIR USE AS SST RECEPTOR SUBTYPE 5 ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2006-12-07 | — | — | WO | disclosed |